Details
Stereochemistry | ACHIRAL |
Molecular Formula | C13H11NO2 |
Molecular Weight | 213.2319 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=C(C=CC=C1)C(=O)NC2=CC=CC=C2
InChI
InChIKey=WKEDVNSFRWHDNR-UHFFFAOYSA-N
InChI=1S/C13H11NO2/c15-12-9-5-4-8-11(12)13(16)14-10-6-2-1-3-7-10/h1-9,15H,(H,14,16)
Molecular Formula | C13H11NO2 |
Molecular Weight | 213.2319 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Salicylanilide (Salinidol). It is anilide of salicylic acid. It is an antifungal agent useful in the treatment of tinea capitis. Due to its inritant action on the skin, the concentration used should be 5 per cent or less. Salicylanilide is an oxidative phosphorylation uncoupler. Salicylanilide inhibits mycobacterial isocitrate lyase. Shows antifungal, antimycobacterial and antihelmitic effects in vivo.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1667699 |
|||
Target ID: CHEMBL2111188 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24953953 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Salinidol Approved UseTinea capitis Launch Date1945 |
PubMed
Title | Date | PubMed |
---|---|---|
Relationship between the structure and antimycobacterial activity of substituted salicylanilides. | 2003 Mar |
|
Total anthelmintic failure to control nematode parasites of small ruminants on government breeding farms in Sabah, East Malaysia. | 2004 Aug |
|
Identification of 14-3-3zeta by chemical affinity with salicylanilide inhibitors of interleukin-12p40 production. | 2008 Sep |
|
2-Hydr-oxy-3-nitro-N-phenyl-benzamide. | 2009 Apr 18 |
|
Salicylanilide esters of N-protected amino acids as novel antimicrobial agents. | 2009 Jan 15 |
|
Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase. | 2012 Sep |
Patents
Sample Use Guides
Tinea capitis treatment: the concentration used should be 5 per cent or less.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24953953
Salicylanilide inhibited Mycobacterium tuberculosis H37Rv 331/88 (assessed as complete growth inhibition after 14 days) with MIC 32uM.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:03:59 GMT 2023
by
admin
on
Fri Dec 15 15:03:59 GMT 2023
|
Record UNII |
LHP8NEY345
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EPA PESTICIDE CODE |
77407
Created by
admin on Fri Dec 15 15:03:59 GMT 2023 , Edited by admin on Fri Dec 15 15:03:59 GMT 2023
|
||
|
NCI_THESAURUS |
C28394
Created by
admin on Fri Dec 15 15:03:59 GMT 2023 , Edited by admin on Fri Dec 15 15:03:59 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SALICYLANILIDE
Created by
admin on Fri Dec 15 15:03:59 GMT 2023 , Edited by admin on Fri Dec 15 15:03:59 GMT 2023
|
PRIMARY | |||
|
6872
Created by
admin on Fri Dec 15 15:03:59 GMT 2023 , Edited by admin on Fri Dec 15 15:03:59 GMT 2023
|
PRIMARY | |||
|
m9737
Created by
admin on Fri Dec 15 15:03:59 GMT 2023 , Edited by admin on Fri Dec 15 15:03:59 GMT 2023
|
PRIMARY | Merck Index | ||
|
239133
Created by
admin on Fri Dec 15 15:03:59 GMT 2023 , Edited by admin on Fri Dec 15 15:03:59 GMT 2023
|
PRIMARY | |||
|
C84142
Created by
admin on Fri Dec 15 15:03:59 GMT 2023 , Edited by admin on Fri Dec 15 15:03:59 GMT 2023
|
PRIMARY | |||
|
DTXSID7021784
Created by
admin on Fri Dec 15 15:03:59 GMT 2023 , Edited by admin on Fri Dec 15 15:03:59 GMT 2023
|
PRIMARY | |||
|
201-727-8
Created by
admin on Fri Dec 15 15:03:59 GMT 2023 , Edited by admin on Fri Dec 15 15:03:59 GMT 2023
|
PRIMARY | |||
|
C034596
Created by
admin on Fri Dec 15 15:03:59 GMT 2023 , Edited by admin on Fri Dec 15 15:03:59 GMT 2023
|
PRIMARY | |||
|
3539
Created by
admin on Fri Dec 15 15:03:59 GMT 2023 , Edited by admin on Fri Dec 15 15:03:59 GMT 2023
|
PRIMARY | |||
|
100000170194
Created by
admin on Fri Dec 15 15:03:59 GMT 2023 , Edited by admin on Fri Dec 15 15:03:59 GMT 2023
|
PRIMARY | |||
|
salicylanilide
Created by
admin on Fri Dec 15 15:03:59 GMT 2023 , Edited by admin on Fri Dec 15 15:03:59 GMT 2023
|
PRIMARY | |||
|
87-17-2
Created by
admin on Fri Dec 15 15:03:59 GMT 2023 , Edited by admin on Fri Dec 15 15:03:59 GMT 2023
|
PRIMARY | |||
|
14881
Created by
admin on Fri Dec 15 15:03:59 GMT 2023 , Edited by admin on Fri Dec 15 15:03:59 GMT 2023
|
PRIMARY | |||
|
LHP8NEY345
Created by
admin on Fri Dec 15 15:03:59 GMT 2023 , Edited by admin on Fri Dec 15 15:03:59 GMT 2023
|
PRIMARY | |||
|
CHEMBL82970
Created by
admin on Fri Dec 15 15:03:59 GMT 2023 , Edited by admin on Fri Dec 15 15:03:59 GMT 2023
|
PRIMARY | |||
|
SUB184004
Created by
admin on Fri Dec 15 15:03:59 GMT 2023 , Edited by admin on Fri Dec 15 15:03:59 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |